Day: August 2, 2015
New Hope for Lung Cancer Patients with FDA Approval of Gefitinib
In July 15, the U. S. Food and Drug (FDA) Administration approved IRESSA (gefitinib) for the first-line treatment of patients with metastatic non-small cell [...]